샘플 요청 목록

 카트 문의
시장보고서
상품코드
2021162

체외진단약 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 범위 - 제품·서비스별, 기술별, 용도별, 최종사용자별, 지역별

In-Vitro Diagnostic Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography
발행일: | 리서치사: 구분자 The Insight Partners | 페이지 정보: 영문 924 Pages | 배송안내 : 즉시배송

    
    
    



가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.
US $ 4,450 금액 안내 화살표 ￦ 6,730,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,450 금액 안내 화살표 ￦ 9,755,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,450 금액 안내 화살표 ￦ 12,780,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

체외진단약 시장은 2025년 1,120억 4,000만 달러에서 2034년까지 2,187억 3,000만 달러로 성장할 것으로 예측됩니다. 2026-2034년에 이 시장은 CAGR 7.8%를 기록할 것으로 전망되고 있습니다. 체외진단 시장의 성장 요인으로는 비침습적이고 환자 친화적인 진단 툴에 대한 수요 증가, 천식 및 COPD(만성폐쇄성폐질환)와 같은 호흡기 질환의 부담 증가, 재택 모니터링에 대한 기술적 진보와 규제적 지원 등을 꼽을 수 있습니다.

체외진단(IVD)이란 혈액, 소변, 조직 등의 생체 시료를 채취하여 일반적으로 검사실, 진료소 또는 진료 현장에서 인체 밖에서 시행하는 의료 검사를 말합니다. 이러한 검사는 질병을 감지하고, 건강 상태를 모니터링하며, 임상적 의사결정을 내리는 데 필수적인 역할을 합니다. IVD에는 면역측정법, 분자진단, 임상화학분석기 등 다양한 기술이 포함됩니다. 이는 조기 진단, 질병 예방 및 맞춤형 의료에서 매우 중요한 역할을 하고 있습니다. 기술의 발전과 함께 IVD는 더욱 빠르고 정확해졌으며, 전 세계에서 환자의 치료 결과를 개선하고 보다 효율적인 의료 시스템을 구축하는 데 도움을 주고 있습니다.

북미 체외진단제 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미에서는 미국이 가장 큰 점유율을 차지하고 있습니다. CDC에 따르면 2023년 미국 성인의 76.4%(약 1억 9,400만 명)가 심장병, 당뇨병, 암과 같은 만성질환을 하나 이상 앓고 있다고 보고하고 있으며, 모든 연령대에서 다발성 질환의 동반이 두드러지게 나타나 빈번한 진단 모니터링 및 관리의 필요성이 강조되고 있습니다. 있습니다. 2023년 당뇨병 유병률은 카운티에 따라 4.4%에서 18.6%까지 다양하며, 정기적인 검사가 필요한 대사성 질환이 널리 퍼져 있음을 반영합니다. 미국암협회의 추정에 따르면 2023년 신규 암 환자 수는 2025년까지 높은 수준을 유지할 것으로 예상되며, 이는 종양학 진단에 대한 수요를 증가시킬 것으로 예상됩니다. 이러한 만성질환 및 감염성 질환의 유병률 추세로 인해 IVD 기술의 사용이 증가하고 있습니다. 왜냐하면 조기 발견, 치료 계획 및 질병 모니터링을 위해서는 일상적인 임상 검사가 필수적이기 때문입니다. 2023년 임상화학 및 면역측정용 차세대 분석기 등 최근 FDA 승인 및 제품 출시로 검사 능력과 속도가 향상되어 진단의 정확성과 활용도가 높아졌다. 분자 진단, 현장 검사, 맞춤형 의료의 발전으로 IVD의 적용 범위가 확대되어 공중 보건 모니터링의 요구를 충족시키고 일상적인 임상 판단의 질을 향상시키고 있습니다.

필수 진단에 대한 접근성 확대와 국가 진단 전략으로 미래 시장 기회 창출

세계의 IVD 시장의 가장 큰 기회 중 하나는 감염성 및 비감염성 질환의 조기 발견, 모니터링 및 관리에 매우 중요한 역할을 하는 필수 진단 약품의 가용성을 높이기 위해 전 세계 정부 및 보건 기관이 협력하여 노력한 결과입니다. 2023년 10월, 세계보건기구(WHO)는 '2023년 필수 진단 리스트(EDL)'을 발표하며 E형 간염 바이러스 신속 진단, 당뇨병 관리를 위한 개인용 혈당 모니터링 기기 등 주요 검사를 추가했습니다. 이번 업데이트는 각국이 영향력 있는 진단에 우선순위를 두고 공중보건 시스템 전반에서 임상 결과를 개선할 수 있도록 지원하는 것을 목표로 합니다.

WHO의 글로벌 진단 우선순위 구상은 2023년 5월 세계보건총회(WHA) 결의안 76.5와도 관련이 있습니다. 이 결의안은 회원국들에게 모든 보건 시스템 수준에서 진단 역량을 강화할 것을 공식적으로 요청했으며, 이 정책 추진은 2024-2025년까지 지속될 예정이며, IVD 제품의 국내 재고 관리 및 우선순위 설정을 위한 이동 지침과 기술 지원을 제공할 예정입니다.

또한 인도와 같은 국가에서는 2024년 3월까지 공공시설에서 정의된 필수 검사의 가용성을 단계적으로 개선하고 빈혈, 당뇨병, 감염성 질환 및 기타 질병에 대한 광범위한 정기 검진을 지원하는 '무료 진단 서비스 구상'가 확대되고 있습니다. 마커와 같은 질병에 대한 광범위한 정기 검진을 지원하고 있습니다.

공공 진단 리스트과 국가 전략에 기반한 이러한 정책 주도적 기회는 그동안 검사 접근성이 낮았던 임상 현장에서 IVD 보급을 위한 구조적 동력을 제공하고 있습니다.

목차

제1장 개요

제2장 체외진단약 시장 구도

제3장 경쟁 구도

제4장 체외진단약 시장 - 주요 업계 동향

제5장 체외진단약 시장 - 세계 시장 분석

제6장 체외진단약 시장의 매출 분석 - 제품별

제7장 체외진단 시장 매출 분석 - 기술별

제8장 체외진단약 시장의 매출 분석 - 용도별

제9장 체외진단약 시장의 매출 분석 - 용도별

제10장 체외진단약 시장의 매출 분석 - 검사 시행 장소별

제11장 체외진단약 시장의 매출 분석 - 검체

제12장 체외진단약 시장의 매출 분석 - 최종사용자

제13장 체외진단약 시장 - 지역 분석

1

KSA 26.05.12

The In-Vitro Diagnostics market is anticipated to grow from US$ 112.04 Billion in 2025 to US$ 218.73 Billion by 2034; the market is expected to register a CAGR of 7.8% from 2026 to 2034. In-Vitro Diagnostics Market growth is attributed to the growing demand for non-invasive and patient-friendly diagnostic tools, growing burden of respiratory diseases such as asthma and COPD, and technological advancements and regulatory support for home monitoring.

In-vitro diagnostics (IVD) refers to medical tests conducted on biological samples such as blood, urine, or tissue outside the human body, typically in laboratories, clinics, or at the point of care. These tests are essential for detecting diseases, monitoring health conditions, and guiding clinical decision-making. IVD includes a wide range of technologies, such as immunoassays, molecular diagnostics, and clinical chemistry analyzers. It plays a critical role in early diagnosis, disease prevention, and personalized medicine. With ongoing technological advancements, IVD is becoming faster, more accurate, and increasingly accessible, supporting improved patient outcomes and more efficient healthcare systems worldwide.

The In-Vitro Diagnostics Market in North America is segmented into the US, Canada, and Mexico. The US held the largest share in North America. According to the CDC, in 2023, 76.4 % of US adults (~194 million) reported at least one chronic condition, such as heart disease, diabetes, or cancer, with multimorbidity notable across age groups, underscoring the need for frequent diagnostic monitoring and management. In 2023, diagnosed diabetes prevalence varied across counties from 4.4 % to 18.6 %, reflecting widespread metabolic disease that necessitates regular testing. According to American Cancer Society estimates, new cancer cases in 2023 and projected into 2025 remained high, reinforcing demand for oncology diagnostics. These patterns of chronic and infectious disease prevalence have increased the use of IVD technologies, as routine laboratory tests are essential for early detection, treatment planning, and disease monitoring. Recent FDA clearances and product launches, including next-generation analyzers for clinical chemistry and immunoassays in 2023, have expanded testing capabilities and speed, making diagnostics more accurate and accessible. Advances in molecular diagnostics, point-of-care testing, and personalized medicine have broadened applications of IVD, aligning with public health surveillance needs and enhancing routine clinical decision-making.

Expansion of Essential Diagnostics Access and National Diagnostic Strategies to Provide Market Opportunities in Future

One of the largest opportunities in the global IVD market is the result of the concerted efforts of governments and health organizations worldwide in increasing the availability of essential diagnostics, which play a critical role in the early detection, monitoring, and management of both infectious and non-communicable diseases . In October 2023, the World Health Organization (WHO) released its 2023 Essential Diagnostics List (EDL), adding key tests such as rapid diagnostics for hepatitis E virus and personal glucose monitoring devices for diabetes management; these updates were designed to help countries prioritize high-impact diagnostics and improve clinical outcomes across public health systems.

The WHO's global diagnostics priority initiative also links to the World Health Assembly (WHA) Resolution 76.5 in May 2023, which formally called on member states to strengthen diagnostics capacity at all health system levels a policy push that continues through 2024-2025 with implementation guidance and technical support for national inventory and prioritization of IVD products.

Further, within countries such as India, the expansion of the Free Diagnostics Service Initiative under the National Health Mission led to progressive improvement in the availability of a defined set of essential tests across public facilities by March 2024, supporting widespread routine screening for conditions such as anemia, diabetes, and infectious disease markers.

These policy-driven opportunities anchored in official diagnostics lists and national strategies provide structural momentum for IVD uptake across clinical settings where testing accessibility historically lagged.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, American Cancer Society, Statistics Canada, the National Institute of Statistics and Geography (INEGI), Robert Koch Institute (RKI), the International Diabetes Federation (IDF) are among the primary and secondary sources referred to while preparing the In-Vitro Diagnostics Market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. In-Vitro Diagnostic Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
  • 2.10 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. In-Vitro Diagnostic Market - Key Industry Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Future Trends
  • 4.5 Impact of Drivers and Restraints

5. In-Vitro Diagnostic Market - Global Market Analysis

  • 5.1 In-Vitro Diagnostic Market Revenue (US$ Million), 2021-2034
  • 5.2 In-Vitro Diagnostic Market Forecast and Analysis

6. In-Vitro Diagnostic Market Revenue Analysis - Product

  • 6.1 In-Vitro Diagnostic Market Forecasts and Analysis by Product
    • 6.1.1 Reagents and Kits
      • 6.1.1.1 Overview
      • 6.1.1.2 Reagents and Kits: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.1 Clinical Chemistry
          • 6.1.1.2.1.1 Overview
          • 6.1.1.2.1.2 Clinical Chemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.2 Immunoassay
          • 6.1.1.2.2.1 Overview
          • 6.1.1.2.2.2 Immunoassay: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.3 Hematology and Coagulation
          • 6.1.1.2.3.1 Overview
          • 6.1.1.2.3.2 Hematology and Coagulation: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.4 Molecular Diagnostics
          • 6.1.1.2.4.1 Overview
          • 6.1.1.2.4.2 Molecular Diagnostics: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.5 Microbiology and Infectious Disease
          • 6.1.1.2.5.1 Overview
          • 6.1.1.2.5.2 Microbiology and Infectious Disease: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.6 Blood Gas and Electrolyte
          • 6.1.1.2.6.1 Overview
          • 6.1.1.2.6.2 Blood Gas and Electrolyte: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.7 Flow Cytometers
          • 6.1.1.2.7.1 Overview
          • 6.1.1.2.7.2 Flow Cytometers: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.8 Urinalysis
          • 6.1.1.2.8.1 Overview
          • 6.1.1.2.8.2 Urinalysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.9 Blood Bank and Transfusion Medicine
          • 6.1.1.2.9.1 Overview
          • 6.1.1.2.9.2 Blood Bank and Transfusion Medicine: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.10 Specimen Prep and Ancillary
          • 6.1.1.2.10.1 Overview
          • 6.1.1.2.10.2 Specimen Prep and Ancillary: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.11 Specialty and Research-Grade
          • 6.1.1.2.11.1 Overview
          • 6.1.1.2.11.2 Specialty and Research-Grade: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Instruments
      • 6.1.2.1 Overview
      • 6.1.2.2 Instruments: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Software and Services
      • 6.1.3.1 Overview
      • 6.1.3.2 Software and Services: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

7. In-Vitro Diagnostic Market Revenue Analysis - Technology

  • 7.1 In-Vitro Diagnostic Market Forecasts and Analysis by Technology
    • 7.1.1 Immunoassay or Immunochemistry
      • 7.1.1.1 Overview
      • 7.1.1.2 Immunoassay or Immunochemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
          • 7.1.1.2.1.1 Overview
          • 7.1.1.2.1.2 Enzyme-Linked Immunosorbent Assay (ELISA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.2 Chemiluminescent Immunoassay (CLIA or ECLIA or Flash CLIA or Glow CLIA)
          • 7.1.1.2.2.1 Overview
          • 7.1.1.2.2.2 Chemiluminescent Immunoassay (CLIA or ECLIA or Flash CLIA or Glow CLIA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.3 Fluorescent Immunoassay (FIA)
          • 7.1.1.2.3.1 Overview
          • 7.1.1.2.3.2 Fluorescent Immunoassay (FIA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.4 Radioimmunoassay (RIA)
          • 7.1.1.2.4.1 Overview
          • 7.1.1.2.4.2 Radioimmunoassay (RIA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.5 Latex Agglutination
          • 7.1.1.2.5.1 Overview
          • 7.1.1.2.5.2 Latex Agglutination: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.6 Nephelometry
          • 7.1.1.2.6.1 Overview
          • 7.1.1.2.6.2 Nephelometry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.7 Turbidimetry
          • 7.1.1.2.7.1 Overview
          • 7.1.1.2.7.2 Turbidimetry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Immunochromatography
      • 7.1.2.1 Overview
      • 7.1.2.2 Immunochromatography: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Cellular analysis
      • 7.1.3.1 Overview
      • 7.1.3.2 Cellular analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.3.2.1 Electrical Impedance
          • 7.1.3.2.1.1 Overview
          • 7.1.3.2.1.2 Electrical Impedance: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.3.2.2 Digital cell morphology analysis
          • 7.1.3.2.2.1 Overview
          • 7.1.3.2.2.2 Digital cell morphology analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.4 Proteomic or metabolomic
      • 7.1.4.1 Overview
      • 7.1.4.2 Proteomic or metabolomic: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.5 Sensor technology
      • 7.1.5.1 Overview
      • 7.1.5.2 Sensor technology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.5.2.1 Biochemistry
          • 7.1.5.2.1.1 Overview
          • 7.1.5.2.1.2 Biochemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.5.2.2 Electrolyte
          • 7.1.5.2.2.1 Overview
          • 7.1.5.2.2.2 Electrolyte: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.6 Miniaturized systems
      • 7.1.6.1 Overview
      • 7.1.6.2 Miniaturized systems: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.7 Multiplex technology
      • 7.1.7.1 Overview
      • 7.1.7.2 Multiplex technology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.8 Optical detection
      • 7.1.8.1 Overview
      • 7.1.8.2 Optical detection: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.9 Electrochemical analysis
      • 7.1.9.1 Overview
      • 7.1.9.2 Electrochemical analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.10 Separation technology
      • 7.1.10.1 Overview
      • 7.1.10.2 Separation technology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.1 and 50
          • 7.1.10.2.1.1 Overview
          • 7.1.10.2.1.2 and 50: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.2
          • 7.1.10.2.2.1 Overview
          • 7.1.10.2.2.2: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.3 5
          • 7.1.10.2.3.1 Overview
          • 7.1.10.2.3.2 5: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.11 Molecular Diagnosis
      • 7.1.11.1 Overview
      • 7.1.11.2 Molecular Diagnosis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.12 Analytical chemistry
      • 7.1.12.1 Overview
      • 7.1.12.2 Analytical chemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.13 Molecular amplification
      • 7.1.13.1 Overview
      • 7.1.13.2 Molecular amplification: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.14 Molecular genomics
      • 7.1.14.1 Overview
      • 7.1.14.2 Molecular genomics: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.14.2.1 Sequencing (Sanger)
          • 7.1.14.2.1.1 Overview
          • 7.1.14.2.1.2 Sequencing (Sanger): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.14.2.2 Next-Generation Sequencing (NGS)
          • 7.1.14.2.2.1 Overview
          • 7.1.14.2.2.2 Next-Generation Sequencing (NGS): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.15 High-throughput molecular
      • 7.1.15.1 Overview
      • 7.1.15.2 High-throughput molecular: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.16 Genetic Analysis
      • 7.1.16.1 Overview
      • 7.1.16.2 Genetic Analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

8. In-Vitro Diagnostic Market Revenue Analysis - Application

  • 8.1 In-Vitro Diagnostic Market Forecasts and Analysis by Application
    • 8.1.1 Infectious Diseases
      • 8.1.1.1 Overview
      • 8.1.1.2 Infectious Diseases: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Oncology
      • 8.1.2.1 Overview
      • 8.1.2.2 Oncology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Cardiology
      • 8.1.3.1 Overview
      • 8.1.3.2 Cardiology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Nephrology
      • 8.1.4.1 Overview
      • 8.1.4.2 Nephrology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.5 Diabetes
      • 8.1.5.1 Overview
      • 8.1.5.2 Diabetes: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.6 Genetic Diseases
      • 8.1.6.1 Overview
      • 8.1.6.2 Genetic Diseases: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.7 Blood Grouping and Testing
      • 8.1.7.1 Overview
      • 8.1.7.2 Blood Grouping and Testing: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.8 Allergy Diagnostics
      • 8.1.8.1 Overview
      • 8.1.8.2 Allergy Diagnostics: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.9 Gastrointestinal Diseases
      • 8.1.9.1 Overview
      • 8.1.9.2 Gastrointestinal Diseases: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.10 Immune System Disorders
      • 8.1.10.1 Overview
      • 8.1.10.2 Immune System Disorders: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.11 Others
      • 8.1.11.1 Overview
      • 8.1.11.2 Others: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

9. In-Vitro Diagnostic Market Revenue Analysis - Usability

  • 9.1 In-Vitro Diagnostic Market Forecasts and Analysis by Usability
    • 9.1.1 Disposable Devices
      • 9.1.1.1 Overview
      • 9.1.1.2 Disposable Devices: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.2 Reusable Equipment
      • 9.1.2.1 Overview
      • 9.1.2.2 Reusable Equipment: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

10. In-Vitro Diagnostic Market Revenue Analysis - Site Of Testing

  • 10.1 In-Vitro Diagnostic Market Forecasts and Analysis by Site Of Testing
    • 10.1.1 Laboratory Tests
      • 10.1.1.1 Overview
      • 10.1.1.2 Laboratory Tests: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.2 Point of Care Tests
      • 10.1.2.1 Overview
      • 10.1.2.2 Point of Care Tests: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

11. In-Vitro Diagnostic Market Revenue Analysis - Specimen

  • 11.1 In-Vitro Diagnostic Market Forecasts and Analysis by Specimen
    • 11.1.1 Blood Serum and Plasma
      • 11.1.1.1 Overview
      • 11.1.1.2 Blood Serum and Plasma: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.2 Saliva Specimens
      • 11.1.2.1 Overview
      • 11.1.2.2 Saliva Specimens: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.3 Urine Specimens
      • 11.1.3.1 Overview
      • 11.1.3.2 Urine Specimens: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.4 Others
      • 11.1.4.1 Overview
      • 11.1.4.2 Others: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

12. In-Vitro Diagnostic Market Revenue Analysis - End User

  • 12.1 In-Vitro Diagnostic Market Forecasts and Analysis by End User
    • 12.1.1 Hospitals
      • 12.1.1.1 Overview
      • 12.1.1.2 Hospitals: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.2 Clinical Laboratories
      • 12.1.2.1 Overview
      • 12.1.2.2 Clinical Laboratories: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.3 Home Care
      • 12.1.3.1 Overview
      • 12.1.3.2 Home Care: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.4 Others
      • 12.1.4.1 Overview
      • 12.1.4.2 Others: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

13. In-Vitro Diagnostic Market - Geographical Analysis

  • 13.1 North America
    • 13.1.1 North America In-Vitro Diagnostic Market Overview
    • 13.1.2 North America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.1.3 North America: In-Vitro Diagnostic Market - By Segmentation
      • 13.1.3.1 Product
      • 13.1.3.2 Reagents And Kits
      • 13.1.3.3 Instruments
      • 13.1.3.4 Clinical Chemistry Analyzers
      • 13.1.3.5 Immunoassay Instruments
      • 13.1.3.6 Urinalysis Instruments
      • 13.1.3.7 Technology
      • 13.1.3.8 Immunoassay Or Immunochemistry
      • 13.1.3.9 Immunochromatography
      • 13.1.3.10 Cellular Analysis
      • 13.1.3.11 Sensor Technology
      • 13.1.3.12 Separation Technology
      • 13.1.3.13 Molecular Diagnosis
      • 13.1.3.14 Molecular Genomics
      • 13.1.3.15 Application
      • 13.1.3.16 Usability
      • 13.1.3.17 Site Of Testing
      • 13.1.3.18 Specimen
      • 13.1.3.19 End User
    • 13.1.4 North America: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.1.4.1 United States Market
        • 13.1.4.1.1 United States: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.1.2 United States: In-Vitro Diagnostic Market - By Segmentation
          • 13.1.4.1.2.1 Product
          • 13.1.4.1.2.2 Reagents And Kits
          • 13.1.4.1.2.3 Instruments
          • 13.1.4.1.2.4 Clinical Chemistry Analyzers
          • 13.1.4.1.2.5 Immunoassay Instruments
          • 13.1.4.1.2.6 Urinalysis Instruments
          • 13.1.4.1.2.7 Technology
          • 13.1.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.1.4.1.2.9 Immunochromatography
          • 13.1.4.1.2.10 Cellular Analysis
          • 13.1.4.1.2.11 Sensor Technology
          • 13.1.4.1.2.12 Separation Technology
          • 13.1.4.1.2.13 Molecular Diagnosis
          • 13.1.4.1.2.14 Molecular Genomics
          • 13.1.4.1.2.15 Application
          • 13.1.4.1.2.16 Usability
          • 13.1.4.1.2.17 Site Of Testing
          • 13.1.4.1.2.18 Specimen
          • 13.1.4.1.2.19 End User
      • 13.1.4.2 Canada Market
        • 13.1.4.2.1 Canada: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.2.2 Canada: In-Vitro Diagnostic Market - By Segmentation
          • 13.1.4.2.2.1 Product
          • 13.1.4.2.2.2 Reagents And Kits
          • 13.1.4.2.2.3 Instruments
          • 13.1.4.2.2.4 Clinical Chemistry Analyzers
          • 13.1.4.2.2.5 Immunoassay Instruments
          • 13.1.4.2.2.6 Urinalysis Instruments
          • 13.1.4.2.2.7 Technology
          • 13.1.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.1.4.2.2.9 Immunochromatography
          • 13.1.4.2.2.10 Cellular Analysis
          • 13.1.4.2.2.11 Sensor Technology
          • 13.1.4.2.2.12 Separation Technology
          • 13.1.4.2.2.13 Molecular Diagnosis
          • 13.1.4.2.2.14 Molecular Genomics
          • 13.1.4.2.2.15 Application
          • 13.1.4.2.2.16 Usability
          • 13.1.4.2.2.17 Site Of Testing
          • 13.1.4.2.2.18 Specimen
          • 13.1.4.2.2.19 End User
      • 13.1.4.3 Mexico Market
        • 13.1.4.3.1 Mexico: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.3.2 Mexico: In-Vitro Diagnostic Market - By Segmentation
          • 13.1.4.3.2.1 Product
          • 13.1.4.3.2.2 Reagents And Kits
          • 13.1.4.3.2.3 Instruments
          • 13.1.4.3.2.4 Clinical Chemistry Analyzers
          • 13.1.4.3.2.5 Immunoassay Instruments
          • 13.1.4.3.2.6 Urinalysis Instruments
          • 13.1.4.3.2.7 Technology
          • 13.1.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.1.4.3.2.9 Immunochromatography
          • 13.1.4.3.2.10 Cellular Analysis
          • 13.1.4.3.2.11 Sensor Technology
          • 13.1.4.3.2.12 Separation Technology
          • 13.1.4.3.2.13 Molecular Diagnosis
          • 13.1.4.3.2.14 Molecular Genomics
          • 13.1.4.3.2.15 Application
          • 13.1.4.3.2.16 Usability
          • 13.1.4.3.2.17 Site Of Testing
          • 13.1.4.3.2.18 Specimen
          • 13.1.4.3.2.19 End User
  • 13.2 Europe
    • 13.2.1 Europe In-Vitro Diagnostic Market Overview
    • 13.2.2 Europe: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.2.3 Europe: In-Vitro Diagnostic Market - By Segmentation
      • 13.2.3.1 Product
      • 13.2.3.2 Reagents And Kits
      • 13.2.3.3 Instruments
      • 13.2.3.4 Clinical Chemistry Analyzers
      • 13.2.3.5 Immunoassay Instruments
      • 13.2.3.6 Urinalysis Instruments
      • 13.2.3.7 Technology
      • 13.2.3.8 Immunoassay Or Immunochemistry
      • 13.2.3.9 Immunochromatography
      • 13.2.3.10 Cellular Analysis
      • 13.2.3.11 Sensor Technology
      • 13.2.3.12 Separation Technology
      • 13.2.3.13 Molecular Diagnosis
      • 13.2.3.14 Molecular Genomics
      • 13.2.3.15 Application
      • 13.2.3.16 Usability
      • 13.2.3.17 Site Of Testing
      • 13.2.3.18 Specimen
      • 13.2.3.19 End User
    • 13.2.4 Europe: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.2.4.1 Germany Market
        • 13.2.4.1.1 Germany: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.1.2 Germany: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.1.2.1 Product
          • 13.2.4.1.2.2 Reagents And Kits
          • 13.2.4.1.2.3 Instruments
          • 13.2.4.1.2.4 Clinical Chemistry Analyzers
          • 13.2.4.1.2.5 Immunoassay Instruments
          • 13.2.4.1.2.6 Urinalysis Instruments
          • 13.2.4.1.2.7 Technology
          • 13.2.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.1.2.9 Immunochromatography
          • 13.2.4.1.2.10 Cellular Analysis
          • 13.2.4.1.2.11 Sensor Technology
          • 13.2.4.1.2.12 Separation Technology
          • 13.2.4.1.2.13 Molecular Diagnosis
          • 13.2.4.1.2.14 Molecular Genomics
          • 13.2.4.1.2.15 Application
          • 13.2.4.1.2.16 Usability
          • 13.2.4.1.2.17 Site Of Testing
          • 13.2.4.1.2.18 Specimen
          • 13.2.4.1.2.19 End User
      • 13.2.4.2 France Market
        • 13.2.4.2.1 France: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.2.2 France: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.2.2.1 Product
          • 13.2.4.2.2.2 Reagents And Kits
          • 13.2.4.2.2.3 Instruments
          • 13.2.4.2.2.4 Clinical Chemistry Analyzers
          • 13.2.4.2.2.5 Immunoassay Instruments
          • 13.2.4.2.2.6 Urinalysis Instruments
          • 13.2.4.2.2.7 Technology
          • 13.2.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.2.2.9 Immunochromatography
          • 13.2.4.2.2.10 Cellular Analysis
          • 13.2.4.2.2.11 Sensor Technology
          • 13.2.4.2.2.12 Separation Technology
          • 13.2.4.2.2.13 Molecular Diagnosis
          • 13.2.4.2.2.14 Molecular Genomics
          • 13.2.4.2.2.15 Application
          • 13.2.4.2.2.16 Usability
          • 13.2.4.2.2.17 Site Of Testing
          • 13.2.4.2.2.18 Specimen
          • 13.2.4.2.2.19 End User
      • 13.2.4.3 Italy Market
        • 13.2.4.3.1 Italy: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.3.2 Italy: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.3.2.1 Product
          • 13.2.4.3.2.2 Reagents And Kits
          • 13.2.4.3.2.3 Instruments
          • 13.2.4.3.2.4 Clinical Chemistry Analyzers
          • 13.2.4.3.2.5 Immunoassay Instruments
          • 13.2.4.3.2.6 Urinalysis Instruments
          • 13.2.4.3.2.7 Technology
          • 13.2.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.3.2.9 Immunochromatography
          • 13.2.4.3.2.10 Cellular Analysis
          • 13.2.4.3.2.11 Sensor Technology
          • 13.2.4.3.2.12 Separation Technology
          • 13.2.4.3.2.13 Molecular Diagnosis
          • 13.2.4.3.2.14 Molecular Genomics
          • 13.2.4.3.2.15 Application
          • 13.2.4.3.2.16 Usability
          • 13.2.4.3.2.17 Site Of Testing
          • 13.2.4.3.2.18 Specimen
          • 13.2.4.3.2.19 End User
      • 13.2.4.4 United Kingdom Market
        • 13.2.4.4.1 United Kingdom: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.4.2 United Kingdom: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.4.2.1 Product
          • 13.2.4.4.2.2 Reagents And Kits
          • 13.2.4.4.2.3 Instruments
          • 13.2.4.4.2.4 Clinical Chemistry Analyzers
          • 13.2.4.4.2.5 Immunoassay Instruments
          • 13.2.4.4.2.6 Urinalysis Instruments
          • 13.2.4.4.2.7 Technology
          • 13.2.4.4.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.4.2.9 Immunochromatography
          • 13.2.4.4.2.10 Cellular Analysis
          • 13.2.4.4.2.11 Sensor Technology
          • 13.2.4.4.2.12 Separation Technology
          • 13.2.4.4.2.13 Molecular Diagnosis
          • 13.2.4.4.2.14 Molecular Genomics
          • 13.2.4.4.2.15 Application
          • 13.2.4.4.2.16 Usability
          • 13.2.4.4.2.17 Site Of Testing
          • 13.2.4.4.2.18 Specimen
          • 13.2.4.4.2.19 End User
      • 13.2.4.5 Spain Market
        • 13.2.4.5.1 Spain: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.5.2 Spain: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.5.2.1 Product
          • 13.2.4.5.2.2 Reagents And Kits
          • 13.2.4.5.2.3 Instruments
          • 13.2.4.5.2.4 Clinical Chemistry Analyzers
          • 13.2.4.5.2.5 Immunoassay Instruments
          • 13.2.4.5.2.6 Urinalysis Instruments
          • 13.2.4.5.2.7 Technology
          • 13.2.4.5.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.5.2.9 Immunochromatography
          • 13.2.4.5.2.10 Cellular Analysis
          • 13.2.4.5.2.11 Sensor Technology
          • 13.2.4.5.2.12 Separation Technology
          • 13.2.4.5.2.13 Molecular Diagnosis
          • 13.2.4.5.2.14 Molecular Genomics
          • 13.2.4.5.2.15 Application
          • 13.2.4.5.2.16 Usability
          • 13.2.4.5.2.17 Site Of Testing
          • 13.2.4.5.2.18 Specimen
          • 13.2.4.5.2.19 End User
      • 13.2.4.6 Rest of Europe Market
        • 13.2.4.6.1 Rest of Europe: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.6.2 Rest of Europe: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.6.2.1 Product
          • 13.2.4.6.2.2 Reagents And Kits
          • 13.2.4.6.2.3 Instruments
          • 13.2.4.6.2.4 Clinical Chemistry Analyzers
          • 13.2.4.6.2.5 Immunoassay Instruments
          • 13.2.4.6.2.6 Urinalysis Instruments
          • 13.2.4.6.2.7 Technology
          • 13.2.4.6.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.6.2.9 Immunochromatography
          • 13.2.4.6.2.10 Cellular Analysis
          • 13.2.4.6.2.11 Sensor Technology
          • 13.2.4.6.2.12 Separation Technology
          • 13.2.4.6.2.13 Molecular Diagnosis
          • 13.2.4.6.2.14 Molecular Genomics
          • 13.2.4.6.2.15 Application
          • 13.2.4.6.2.16 Usability
          • 13.2.4.6.2.17 Site Of Testing
          • 13.2.4.6.2.18 Specimen
          • 13.2.4.6.2.19 End User
  • 13.3 Asia Pacific
    • 13.3.1 Asia Pacific In-Vitro Diagnostic Market Overview
    • 13.3.2 Asia Pacific: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.3.3 Asia Pacific: In-Vitro Diagnostic Market - By Segmentation
      • 13.3.3.1 Product
      • 13.3.3.2 Reagents And Kits
      • 13.3.3.3 Instruments
      • 13.3.3.4 Clinical Chemistry Analyzers
      • 13.3.3.5 Immunoassay Instruments
      • 13.3.3.6 Urinalysis Instruments
      • 13.3.3.7 Technology
      • 13.3.3.8 Immunoassay Or Immunochemistry
      • 13.3.3.9 Immunochromatography
      • 13.3.3.10 Cellular Analysis
      • 13.3.3.11 Sensor Technology
      • 13.3.3.12 Separation Technology
      • 13.3.3.13 Molecular Diagnosis
      • 13.3.3.14 Molecular Genomics
      • 13.3.3.15 Application
      • 13.3.3.16 Usability
      • 13.3.3.17 Site Of Testing
      • 13.3.3.18 Specimen
      • 13.3.3.19 End User
    • 13.3.4 Asia Pacific: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.3.4.1 China Market
        • 13.3.4.1.1 China: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.1.2 China: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.1.2.1 Product
          • 13.3.4.1.2.2 Reagents And Kits
          • 13.3.4.1.2.3 Instruments
          • 13.3.4.1.2.4 Clinical Chemistry Analyzers
          • 13.3.4.1.2.5 Immunoassay Instruments
          • 13.3.4.1.2.6 Urinalysis Instruments
          • 13.3.4.1.2.7 Technology
          • 13.3.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.1.2.9 Immunochromatography
          • 13.3.4.1.2.10 Cellular Analysis
          • 13.3.4.1.2.11 Sensor Technology
          • 13.3.4.1.2.12 Separation Technology
          • 13.3.4.1.2.13 Molecular Diagnosis
          • 13.3.4.1.2.14 Molecular Genomics
          • 13.3.4.1.2.15 Application
          • 13.3.4.1.2.16 Usability
          • 13.3.4.1.2.17 Site Of Testing
          • 13.3.4.1.2.18 Specimen
          • 13.3.4.1.2.19 End User
      • 13.3.4.2 Japan Market
        • 13.3.4.2.1 Japan: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.2.2 Japan: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.2.2.1 Product
          • 13.3.4.2.2.2 Reagents And Kits
          • 13.3.4.2.2.3 Instruments
          • 13.3.4.2.2.4 Clinical Chemistry Analyzers
          • 13.3.4.2.2.5 Immunoassay Instruments
          • 13.3.4.2.2.6 Urinalysis Instruments
          • 13.3.4.2.2.7 Technology
          • 13.3.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.2.2.9 Immunochromatography
          • 13.3.4.2.2.10 Cellular Analysis
          • 13.3.4.2.2.11 Sensor Technology
          • 13.3.4.2.2.12 Separation Technology
          • 13.3.4.2.2.13 Molecular Diagnosis
          • 13.3.4.2.2.14 Molecular Genomics
          • 13.3.4.2.2.15 Application
          • 13.3.4.2.2.16 Usability
          • 13.3.4.2.2.17 Site Of Testing
          • 13.3.4.2.2.18 Specimen
          • 13.3.4.2.2.19 End User
      • 13.3.4.3 India Market
        • 13.3.4.3.1 India: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.3.2 India: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.3.2.1 Product
          • 13.3.4.3.2.2 Reagents And Kits
          • 13.3.4.3.2.3 Instruments
          • 13.3.4.3.2.4 Clinical Chemistry Analyzers
          • 13.3.4.3.2.5 Immunoassay Instruments
          • 13.3.4.3.2.6 Urinalysis Instruments
          • 13.3.4.3.2.7 Technology
          • 13.3.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.3.2.9 Immunochromatography
          • 13.3.4.3.2.10 Cellular Analysis
          • 13.3.4.3.2.11 Sensor Technology
          • 13.3.4.3.2.12 Separation Technology
          • 13.3.4.3.2.13 Molecular Diagnosis
          • 13.3.4.3.2.14 Molecular Genomics
          • 13.3.4.3.2.15 Application
          • 13.3.4.3.2.16 Usability
          • 13.3.4.3.2.17 Site Of Testing
          • 13.3.4.3.2.18 Specimen
          • 13.3.4.3.2.19 End User
      • 13.3.4.4 Australia Market
        • 13.3.4.4.1 Australia: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.4.2 Australia: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.4.2.1 Product
          • 13.3.4.4.2.2 Reagents And Kits
          • 13.3.4.4.2.3 Instruments
          • 13.3.4.4.2.4 Clinical Chemistry Analyzers
          • 13.3.4.4.2.5 Immunoassay Instruments
          • 13.3.4.4.2.6 Urinalysis Instruments
          • 13.3.4.4.2.7 Technology
          • 13.3.4.4.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.4.2.9 Immunochromatography
          • 13.3.4.4.2.10 Cellular Analysis
          • 13.3.4.4.2.11 Sensor Technology
          • 13.3.4.4.2.12 Separation Technology
          • 13.3.4.4.2.13 Molecular Diagnosis
          • 13.3.4.4.2.14 Molecular Genomics
          • 13.3.4.4.2.15 Application
          • 13.3.4.4.2.16 Usability
          • 13.3.4.4.2.17 Site Of Testing
          • 13.3.4.4.2.18 Specimen
          • 13.3.4.4.2.19 End User
      • 13.3.4.5 South Korea Market
        • 13.3.4.5.1 South Korea: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.5.2 South Korea: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.5.2.1 Product
          • 13.3.4.5.2.2 Reagents And Kits
          • 13.3.4.5.2.3 Instruments
          • 13.3.4.5.2.4 Clinical Chemistry Analyzers
          • 13.3.4.5.2.5 Immunoassay Instruments
          • 13.3.4.5.2.6 Urinalysis Instruments
          • 13.3.4.5.2.7 Technology
          • 13.3.4.5.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.5.2.9 Immunochromatography
          • 13.3.4.5.2.10 Cellular Analysis
          • 13.3.4.5.2.11 Sensor Technology
          • 13.3.4.5.2.12 Separation Technology
          • 13.3.4.5.2.13 Molecular Diagnosis
          • 13.3.4.5.2.14 Molecular Genomics
          • 13.3.4.5.2.15 Application
          • 13.3.4.5.2.16 Usability
          • 13.3.4.5.2.17 Site Of Testing
          • 13.3.4.5.2.18 Specimen
          • 13.3.4.5.2.19 End User
      • 13.3.4.6 Rest of Asia Pacific Market
        • 13.3.4.6.1 Rest of Asia Pacific: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.6.2 Rest of Asia Pacific: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.6.2.1 Product
          • 13.3.4.6.2.2 Reagents And Kits
          • 13.3.4.6.2.3 Instruments
          • 13.3.4.6.2.4 Clinical Chemistry Analyzers
          • 13.3.4.6.2.5 Immunoassay Instruments
          • 13.3.4.6.2.6 Urinalysis Instruments
          • 13.3.4.6.2.7 Technology
          • 13.3.4.6.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.6.2.9 Immunochromatography
          • 13.3.4.6.2.10 Cellular Analysis
          • 13.3.4.6.2.11 Sensor Technology
          • 13.3.4.6.2.12 Separation Technology
          • 13.3.4.6.2.13 Molecular Diagnosis
          • 13.3.4.6.2.14 Molecular Genomics
          • 13.3.4.6.2.15 Application
          • 13.3.4.6.2.16 Usability
          • 13.3.4.6.2.17 Site Of Testing
          • 13.3.4.6.2.18 Specimen
          • 13.3.4.6.2.19 End User
  • 13.4 Middle East and Africa
    • 13.4.1 Middle East and Africa In-Vitro Diagnostic Market Overview
    • 13.4.2 Middle East and Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.4.3 Middle East and Africa: In-Vitro Diagnostic Market - By Segmentation
      • 13.4.3.1 Product
      • 13.4.3.2 Reagents And Kits
      • 13.4.3.3 Instruments
      • 13.4.3.4 Clinical Chemistry Analyzers
      • 13.4.3.5 Immunoassay Instruments
      • 13.4.3.6 Urinalysis Instruments
      • 13.4.3.7 Technology
      • 13.4.3.8 Immunoassay Or Immunochemistry
      • 13.4.3.9 Immunochromatography
      • 13.4.3.10 Cellular Analysis
      • 13.4.3.11 Sensor Technology
      • 13.4.3.12 Separation Technology
      • 13.4.3.13 Molecular Diagnosis
      • 13.4.3.14 Molecular Genomics
      • 13.4.3.15 Application
      • 13.4.3.16 Usability
      • 13.4.3.17 Site Of Testing
      • 13.4.3.18 Specimen
      • 13.4.3.19 End User
    • 13.4.4 Middle East and Africa: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.4.4.1 South Africa Market
        • 13.4.4.1.1 South Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.1.2 South Africa: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.1.2.1 Product
          • 13.4.4.1.2.2 Reagents And Kits
          • 13.4.4.1.2.3 Instruments
          • 13.4.4.1.2.4 Clinical Chemistry Analyzers
          • 13.4.4.1.2.5 Immunoassay Instruments
          • 13.4.4.1.2.6 Urinalysis Instruments
          • 13.4.4.1.2.7 Technology
          • 13.4.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.1.2.9 Immunochromatography
          • 13.4.4.1.2.10 Cellular Analysis
          • 13.4.4.1.2.11 Sensor Technology
          • 13.4.4.1.2.12 Separation Technology
          • 13.4.4.1.2.13 Molecular Diagnosis
          • 13.4.4.1.2.14 Molecular Genomics
          • 13.4.4.1.2.15 Application
          • 13.4.4.1.2.16 Usability
          • 13.4.4.1.2.17 Site Of Testing
          • 13.4.4.1.2.18 Specimen
          • 13.4.4.1.2.19 End User
      • 13.4.4.2 Saudi Arabia Market
        • 13.4.4.2.1 Saudi Arabia: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.2.2 Saudi Arabia: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.2.2.1 Product
          • 13.4.4.2.2.2 Reagents And Kits
          • 13.4.4.2.2.3 Instruments
          • 13.4.4.2.2.4 Clinical Chemistry Analyzers
          • 13.4.4.2.2.5 Immunoassay Instruments
          • 13.4.4.2.2.6 Urinalysis Instruments
          • 13.4.4.2.2.7 Technology
          • 13.4.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.2.2.9 Immunochromatography
          • 13.4.4.2.2.10 Cellular Analysis
          • 13.4.4.2.2.11 Sensor Technology
          • 13.4.4.2.2.12 Separation Technology
          • 13.4.4.2.2.13 Molecular Diagnosis
          • 13.4.4.2.2.14 Molecular Genomics
          • 13.4.4.2.2.15 Application
          • 13.4.4.2.2.16 Usability
          • 13.4.4.2.2.17 Site Of Testing
          • 13.4.4.2.2.18 Specimen
          • 13.4.4.2.2.19 End User
      • 13.4.4.3 United Arab Emirates Market
        • 13.4.4.3.1 United Arab Emirates: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.3.2 United Arab Emirates: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.3.2.1 Product
          • 13.4.4.3.2.2 Reagents And Kits
          • 13.4.4.3.2.3 Instruments
          • 13.4.4.3.2.4 Clinical Chemistry Analyzers
          • 13.4.4.3.2.5 Immunoassay Instruments
          • 13.4.4.3.2.6 Urinalysis Instruments
          • 13.4.4.3.2.7 Technology
          • 13.4.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.3.2.9 Immunochromatography
          • 13.4.4.3.2.10 Cellular Analysis
          • 13.4.4.3.2.11 Sensor Technology
          • 13.4.4.3.2.12 Separation Technology
          • 13.4.4.3.2.13 Molecular Diagnosis
          • 13.4.4.3.2.14 Molecular Genomics
          • 13.4.4.3.2.15 Application
          • 13.4.4.3.2.16 Usability
          • 13.4.4.3.2.17 Site Of Testing
          • 13.4.4.3.2.18 Specimen
          • 13.4.4.3.2.19 End User
      • 13.4.4.4 Rest of Middle East and Africa Market
        • 13.4.4.4.1 Rest of Middle East and Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.4.2 Rest of Middle East and Africa: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.4.2.1 Product
          • 13.4.4.4.2.2 Reagents And Kits
          • 13.4.4.4.2.3 Instruments
          • 13.4.4.4.2.4 Clinical Chemistry Analyzers
          • 13.4.4.4.2.5 Immunoassay Instruments
          • 13.4.4.4.2.6 Urinalysis Instruments
          • 13.4.4.4.2.7 Technology
          • 13.4.4.4.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.4.2.9 Immunochromatography
          • 13.4.4.4.2.10 Cellular Analysis
          • 13.4.4.4.2.11 Sensor Technology
          • 13.4.4.4.2.12 Separation Technology
          • 13.4.4.4.2.13 Molecular Diagnosis
          • 13.4.4.4.2.14 Molecular Genomics
          • 13.4.4.4.2.15 Application
          • 13.4.4.4.2.16 Usability
          • 13.4.4.4.2.17 Site Of Testing
          • 13.4.4.4.2.18 Specimen
          • 13.4.4.4.2.19 End User
  • 13.5 South and Central America
    • 13.5.1 South and Central America In-Vitro Diagnostic Market Overview
    • 13.5.2 South and Central America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.5.3 South and Central America: In-Vitro Diagnostic Market - By Segmentation
      • 13.5.3.1 Product
      • 13.5.3.2 Reagents And Kits
      • 13.5.3.3 Instruments
      • 13.5.3.4 Clinical Chemistry Analyzers
      • 13.5.3.5 Immunoassay Instruments
      • 13.5.3.6 Urinalysis Instruments
      • 13.5.3.7 Technology
      • 13.5.3.8 Immunoassay Or Immunochemistry
      • 13.5.3.9 Immunochromatography
      • 13.5.3.10 Cellular Analysis
      • 13.5.3.11 Sensor Technology
      • 13.5.3.12 Separation Technology
      • 13.5.3.13 Molecular Diagnosis
      • 13.5.3.14 Molecular Genomics
      • 13.5.3.15 Application
      • 13.5.3.16 Usability
      • 13.5.3.17 Site Of Testing
      • 13.5.3.18 Specimen
      • 13.5.3.19 End User
    • 13.5.4 South and Central America: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.5.4.1 Brazil Market
        • 13.5.4.1.1 Brazil: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.1.2 Brazil: In-Vitro Diagnostic Market - By Segmentation
          • 13.5.4.1.2.1 Product
          • 13.5.4.1.2.2 Reagents And Kits
          • 13.5.4.1.2.3 Instruments
          • 13.5.4.1.2.4 Clinical Chemistry Analyzers
          • 13.5.4.1.2.5 Immunoassay Instruments
          • 13.5.4.1.2.6 Urinalysis Instruments
          • 13.5.4.1.2.7 Technology
          • 13.5.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.5.4.1.2.9 Immunochromatography
          • 13.5.4.1.2.10 Cellular Analysis
          • 13.5.4.1.2.11 Sensor Technology
          • 13.5.4.1.2.12 Separation Technology
          • 13.5.4.1.2.13 Molecular Diagnosis
          • 13.5.4.1.2.14 Molecular Genomics
          • 13.5.4.1.2.15 Application
          • 13.5.4.1.2.16 Usability
          • 13.5.4.1.2.17 Site Of Testing
          • 13.5.4.1.2.18 Specimen
          • 13.5.4.1.2.19 End User
      • 13.5.4.2 Argentina Market
        • 13.5.4.2.1 Argentina: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.2.2 Argentina: In-Vitro Diagnostic Market - By Segmentation
          • 13.5.4.2.2.1 Product
          • 13.5.4.2.2.2 Reagents And Kits
          • 13.5.4.2.2.3 Instruments
          • 13.5.4.2.2.4 Clinical Chemistry Analyzers
          • 13.5.4.2.2.5 Immunoassay Instruments
          • 13.5.4.2.2.6 Urinalysis Instruments
          • 13.5.4.2.2.7 Technology
          • 13.5.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.5.4.2.2.9 Immunochromatography
          • 13.5.4.2.2.10 Cellular Analysis
          • 13.5.4.2.2.11 Sensor Technology
          • 13.5.4.2.2.12 Separation Technology
          • 13.5.4.2.2.13 Molecular Diagnosis
          • 13.5.4.2.2.14 Molecular Genomics
          • 13.5.4.2.2.15 Application
          • 13.5.4.2.2.16 Usability
          • 13.5.4.2.2.17 Site Of Testing
          • 13.5.4.2.2.18 Specimen
          • 13.5.4.2.2.19 End User
      • 13.5.4.3 Rest of South and Central America Market
        • 13.5.4.3.1 Rest of South and Central America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.3.2 Rest of South and Central America: In-Vitro Diagnostic Market - By Segmentation
          • 13.5.4.3.2.1 Product
          • 13.5.4.3.2.2 Reagents And Kits
          • 13.5.4.3.2.3 Instruments
          • 13.5.4.3.2.4 Clinical Chemistry Analyzers
          • 13.5.4.3.2.5 Immunoassay Instruments
          • 13.5.4.3.2.6 Urinalysis Instruments
          • 13.5.4.3.2.7 Technology
          • 13.5.4.3.2.8 Immunoassay Or Immunochemistry

1

×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기